Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00563316 · ClinicalTrials.gov registry record · Phase 1

Effect of Panitumumab on the Pharmacokinetics of Irinotecan

A Phase 1 study of Metastatic Colorectal Cancer, sponsored by Amgen.

Completed
Registry status
Phase 1
Development phase
28
Enrollment target
12
Study locations

NCT00563316 is a Phase 1 study of Metastatic Colorectal Cancer that has completed, run by Amgen. The registered enrollment target is 28 participants, below the 185-participant average among 45 other Metastatic Colorectal Cancer trials with a reported enrollment target (85% lower). The trial reports 12 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00563316, a Phase 1 study of Metastatic Colorectal Cancer, has completed, sponsored by Amgen.

COMPLETED
Registry status
Phase 1
Development phase
28 participants
Enrollment target
12
Study locations

Study Summary

The primary objective of this study is to determine if panitumumab affects the pharmacokinetic (PK) profile of irinotecan.

Conditions Studied

Metastatic Colorectal Cancer

Interventions

  • DRUG Irinotecan
  • DRUG Panitumumab

Study Locations (12)

Montana

  • Research Site - Billings
  • Research Site - Billings

North Carolina

  • Research Site - Chapel Hill
  • Research Site - Chapel Hill

Pennsylvania

  • Research Site - Philadelphia
  • Research Site - Philadelphia

Tennessee

  • Research Site - Nashville
  • Research Site - Nashville

British Columbia

  • Research Site - Vancouver
  • Research Site - Vancouver

Ontario

  • Research Site - Toronto
  • Research Site - Toronto

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2008-03
Est. Completion 2010-06
Phase Phase 1

Sponsor

Amgen

558 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00563316

The ClinicalTrials.gov registry entry for NCT00563316 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 185-participant average among 45 other Metastatic Colorectal Cancer trials with a reported enrollment target (85% lower). The listed sponsor is Amgen, which has 558 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Metastatic Colorectal Cancer appearing as the primary indexed condition, and to 2 interventions - of which Irinotecan is the first listed.

NCT00563316 reports 12 study locations spanning 6 distinct geographic areas - top geographies include Montana, North Carolina, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00563316 about?

NCT00563316 is a clinical study titled "Effect of Panitumumab on the Pharmacokinetics of Irinotecan". The primary objective of this study is to determine if panitumumab affects the pharmacokinetic (PK) profile of irinotecan.

What is the current status of trial NCT00563316?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 28 participants. The study started on 2008-03. Estimated completion is 2010-06.

What conditions does trial NCT00563316 study?

This clinical trial studies the following conditions: Metastatic Colorectal Cancer.

What interventions are being tested in trial NCT00563316?

The interventions under investigation include: Irinotecan (DRUG), Panitumumab (DRUG).

Who is sponsoring clinical trial NCT00563316?

This trial is sponsored by Amgen, which has 558 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00563316 being conducted?

This trial has 12 study locations across Montana, North Carolina, Pennsylvania, Tennessee, British Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Metastatic Colorectal Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Metastatic Colorectal Cancer

All registered trials for this condition

Montana

All trials with a study site in Montana

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.